| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/08/2007 | US20070053922 Epitope based vaccines directed towards HPV; side effect reduction; vaccination |
| 03/08/2007 | US20070053921 Nucleic acid and corresponding protein entitled 24P4C12 useful in treatment and detection of cancer |
| 03/08/2007 | US20070053920 Nematode polypeptide adjuvant |
| 03/08/2007 | US20070053919 Compositions including different types of transfer factor, methods for making the compositions, and methods of treatment using the compositions |
| 03/08/2007 | US20070053918 Injectable depots consisting of liposomal aggregates for the delivery of active substances |
| 03/08/2007 | US20070053917 Composition and method for the treatment and prevention of enteric bacterial infections |
| 03/08/2007 | US20070053916 Plasmodium falciparum peptide for use in stimulating immune response to treat and prevent malaria |
| 03/08/2007 | US20070053915 GIPs, a family of polypeptides with transcription factor activity that interact with Goodpasture antigen binding protein |
| 03/08/2007 | US20070053914 Antitumor antibodies, proteins, and uses thereof |
| 03/08/2007 | US20070053913 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor adipor2 (adipor2) |
| 03/08/2007 | US20070053912 Compounds for neutralizing the effects of secreted pla2iia |
| 03/08/2007 | US20070053911 Diagnostics and therapeutics for diseases associated with g-protein coupled proteinase activated receptor 2 (par2) |
| 03/08/2007 | US20070053910 Modulation of s6 kinase activity for the treatment of obesity |
| 03/08/2007 | US20070053909 Method of treating fibrosis |
| 03/08/2007 | US20070053908 Uses of human zven antagonists |
| 03/08/2007 | US20070053907 Uses of human zven antagonists |
| 03/08/2007 | US20070053906 Liquid formulations of tumor necrosis factor-binding proteins |
| 03/08/2007 | US20070053905 treating chondroma and chondrosarcoma by administering humanized anti-PTHrP(1-34) antibody which inhibits binding of parathyroid hormone related peptide to a receptor thereof |
| 03/08/2007 | US20070053904 Antibodies having diagnostic, preventive, therapeutic, and other uses |
| 03/08/2007 | US20070053903 Methods of using pHHLA2 to co-stimulate T-cells |
| 03/08/2007 | US20070053902 Anti-alphabeta3 humanized monoclonal antibodies |
| 03/08/2007 | US20070053901 Optimized Fc variants and methods for their generation |
| 03/08/2007 | US20070053900 High concentration antibody and protein formulations |
| 03/08/2007 | US20070053897 Calcium independent cytosolic phospholipase A2/B enzymes |
| 03/08/2007 | US20070053894 Compound and method for regulating plasminogen activation and cell migration |
| 03/08/2007 | US20070053891 Snail, a new marker for tumour invasion and target protein of new antitumoral compounds |
| 03/08/2007 | US20070053880 Growth differentiation factor-16 |
| 03/08/2007 | US20070053878 Sars |
| 03/08/2007 | US20070053875 Homogeneous preparations of il-28 and il-29 |
| 03/08/2007 | US20070053873 Canine tumor treatment method, pharmaceutical formulation applied thereto, and method of cryogenically preserving cells used therewith |
| 03/08/2007 | US20070053836 Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 03/08/2007 | US20070053835 Antibodies (monoclonal, humanized) conjugated to antigrowth/cytotoxic agents (maytansinoids, calicheamicins); host cells |
| 03/08/2007 | DE102005042544A1 Beeinflussung des kardialen Fc-Rezeptors zur Behandlung der dilatativen Kardiomyopathie Influencing the cardiac Fc receptor for the treatment of dilated cardiomyopathy |
| 03/08/2007 | DE102005041616A1 Melanom-assoziierte MHC Klasse I assoziierte Oligopeptide und deren Verwendungen Melanoma-associated MHC class I-associated oligopeptides and their uses |
| 03/08/2007 | CA2825762A1 Method for enhancing anti-neoplastic activity of an oncolytic virus using modified dendritic cells |
| 03/08/2007 | CA2625951A1 Anti-apoptotic protein antibodies |
| 03/08/2007 | CA2621786A1 Polysaccharide microparticles containing biological agents: there preparation and applications |
| 03/08/2007 | CA2621136A1 Immunological uses of immunodulatory compounds for vaccine and anti-infectious disease therapy |
| 03/08/2007 | CA2621127A1 Treatment with an oncolytic virus and an immunostimulant for in vivo enhancement of immune system recognition of neoplasms |
| 03/08/2007 | CA2621086A1 Use of il-23 and il-17 antagonists to treat autoimmune ocular inflammatory disease |
| 03/08/2007 | CA2621083A1 Immunomodulating tumor necrosis factor receptor 25 (tnfr25) agonists, antagonists and immunotoxins |
| 03/08/2007 | CA2621023A1 Multiple vaccination including serogroup c meningococcus |
| 03/08/2007 | CA2621017A1 Immunotherapeutic treatment for inducing the regression of atherosclerotic plaques |
| 03/08/2007 | CA2620802A1 Engineered anti-il-23 antibodies |
| 03/08/2007 | CA2620774A1 Streptococcus suis polypeptides and polynucleotides encoding same and their use in vaccinal and diagnostic applications |
| 03/08/2007 | CA2620515A1 Immunoglobulins comprising predominantly a glcnacman3glcnac2 glycoform |
| 03/08/2007 | CA2620495A1 Adenoviral vector-based malaria vaccines |
| 03/08/2007 | CA2620470A1 Trail receptor 2 polypeptides and antibodies |
| 03/08/2007 | CA2620351A1 Antibodies and their use in the treatment, prevention and diagnosis of a disease associated with sod1 abnormalities |
| 03/07/2007 | EP1760089A1 Tumor-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules and related anti-cancer vaccine |
| 03/07/2007 | EP1760088A1 Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules |
| 03/07/2007 | EP1760087A1 Novel protein complex and use thereof |
| 03/07/2007 | EP1759709A1 Humanized antibodies against leukocyte adhesion molecule VLA-4 |
| 03/07/2007 | EP1759707A2 Canine tumor treatment method, pharmaceutical formulation applied thereto and method of cryogenically preserving cells used therewith |
| 03/07/2007 | EP1759013A2 Identification of surface-associated antigens for tumor diagnosis and therapy |
| 03/07/2007 | EP1758989A2 Therapeutic reprogramming, hybrid stem cells and maturation |
| 03/07/2007 | EP1758936A2 Optimized dosing with anti-cd4 antibodies for tolerance induction in primates |
| 03/07/2007 | EP1758617A2 Stable liquid and lyophilized formulation of proteins |
| 03/07/2007 | EP1758610A1 Methods of treating cancer using il-21 and monoclonal antibody therapy |
| 03/07/2007 | EP1758609A1 Vaccine against hpv16 and hpv18 and at least another hpv type selected from hpv 31, 45 or 52 |
| 03/07/2007 | EP1430152B1 Gene and protein relating to hepatocellular carcinoma |
| 03/07/2007 | EP1395283B1 Heterologous protection induced by immunization with invaplex vaccine |
| 03/07/2007 | EP1333840B1 M. tuberculosis chaperonin 60.1 and uses thereof |
| 03/07/2007 | EP1279677B1 Gd3-mimetic peptides |
| 03/07/2007 | EP1257695B1 Biomolecules having multiple attachment moieties for binding to a substrate surface |
| 03/07/2007 | EP1210445B1 Recombinant microorganisms |
| 03/07/2007 | EP1194528B1 Monoclonal antibody for factor VIII, which even when present in molar excess inactivates factor VIII only in part and a method for producing such an antibody |
| 03/07/2007 | EP1131414B1 Stable, attenuated rabies virus mutants and live vaccines thereof |
| 03/07/2007 | EP1044013B1 Use of a phosphatidylserine/polypeptide conjugate for inducing autoimmunity in the treatment of cancers |
| 03/07/2007 | EP0585242B2 Wound healing |
| 03/07/2007 | CN1926149A Identification of novel IgE epitopes |
| 03/07/2007 | CN1926147A Nogo受体拮抗剂 Nogo receptor antagonist |
| 03/07/2007 | CN1925888A Identification of antigenically important neisseria antigens by screening insertional mutant libraries with antiserum |
| 03/07/2007 | CN1925871A Polymer-bound antibody concer therapeutic agent |
| 03/07/2007 | CN1925870A DNA vaccine expressing HA1 of equine-2 influenza virus |
| 03/07/2007 | CN1925869A Treatment of neurodegenerative diseases by the use of GPR49 |
| 03/07/2007 | CN1925845A Powdered compositions of sensitive active materials in an at least partially amorphous state |
| 03/07/2007 | CN1925843A Methods and compositions for the production of monoclonal antibodies |
| 03/07/2007 | CN1923289A Hybrid yeast avian influenza vaccine |
| 03/07/2007 | CN1923288A Hybrid yeast influenza vaccine |
| 03/07/2007 | CN1923279A Preparation method of newcastle disease-avian influenza combined emulsion vaccine |
| 03/07/2007 | CN1923278A Mosaic vaccine of Ag85B and ESAT-6 |
| 03/07/2007 | CN1303105C Light and heavy chain variable region genes of monoclonal antibody CAb-2 against human colorectal carcinoma and their application |
| 03/06/2007 | US7186820 Antibody for use in the treatment of rheumatic and osteoarthritis |
| 03/06/2007 | US7186816 Photolyase nucleic acids |
| 03/06/2007 | US7186809 Methods and compositions relating to anti-interleukin-4 receptor antibodies |
| 03/06/2007 | US7186808 Isolated monoclonal antibody encoded by clone accession number PTA-4889. |
| 03/06/2007 | US7186803 Human vanilloid receptor VR3 protein |
| 03/06/2007 | US7186802 Membrane proteins; for treatment of inflammation, asthma, allergy, metastasis of cancer cells, ion transport disorders such as magnesium defects in the kidney, and inflammatory bowel disease |
| 03/06/2007 | US7186697 Delivery system contains a fusion protein having a target moiety and a nucleic acid binding moiety, and a nucleic acid sequence bound to the nucleic acid binding moiety of the fusion protein. The target moiety can be an antibody or a |
| 03/06/2007 | US7186681 Methods of modulating cell migration using galectin-3 |
| 03/06/2007 | US7186542 Generation and recovering of preferential viral particles; obtain cells, infect with virus, extract virus from cells using detergent, recover virus |
| 03/06/2007 | US7186527 Goodpasture antigen binding protein |
| 03/06/2007 | US7186514 Nucleotide sequences coding tumor marker protein for use in diagnosis and/or prognosis of cell proliferative disorders |
| 03/06/2007 | US7186503 Compounds and methods for modulating activation of NF-κB |
| 03/06/2007 | US7186423 repeating solvent extraction using an alcohol, heating and extraction by water to obtain a residue having a stimulating effect on the production of lymphocytes, interleukens and macrophages; rhinitis; influenza; chronic fatigue syndrome; AIDS |
| 03/06/2007 | US7186412 Fusion proteins of Mycobacterium tuberculosis |
| 03/06/2007 | US7186411 Vaccines absorbable by the transmucosal way |
| 03/06/2007 | US7186410 Method for preparing human immunoglobulin concentrates for therapeutic use |
| 03/06/2007 | US7186408 Immunomodulators; for treatment of inflammation |